Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma
2005

Monitoring DNA in Oral Cancer Patients

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): Thomas E, Shaw R J, Risk J M

Primary Institution: The University of Liverpool

Hypothesis

Can genetic alterations in circulating DNA predict outcomes in oral squamous cell carcinoma after surgery?

Conclusion

The study suggests that monitoring circulating DNA can help detect locoregional recurrence in oral cancer patients.

Supporting Evidence

  • 100% of tumors showed allelic imbalance in the study.
  • 67% of patients had presurgery circulating DNA showing allelic imbalance.
  • The study followed patients for a minimum of 2 years post-surgery.

Takeaway

Doctors can check for special DNA in the blood of oral cancer patients to see if the cancer might come back after surgery.

Methodology

DNA was isolated from tumor tissue and plasma samples from six oral cancer patients, and microsatellite analysis was used to measure allelic imbalance.

Potential Biases

Potential contamination with normal DNA could affect the sensitivity of the analysis.

Limitations

The study had a small sample size and lacked immediate postoperative data.

Participant Demographics

Six oral cancer patients were included in the study.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6602801

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication